Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of ASP015K in rheumatoid arthritis patients with an inadequate response to DMARDs has com…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain [Phase 3]
Phase 3 trial update examining prediction of response to certolizumab pegol in rheumatoid arthritis using functional MRI of the brain.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA) [Phase 2]
Phase 2 clinical trial investigating anifrolumab targeting Type I IFN receptor in rheumatoid arthritis patients with high IFN signature.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate [Phase 2]
Phase 2 trial assessing safety and efficacy of Pf-06650833 in rheumatoid arthritis patients with inadequate response to methotrexate; study …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 trial comparing SAIT101 with MabThera/Rituxan in rheumatoid arthritis completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial comparing CELBESTA and CELEBREX in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Donepezil Attenuate Postoperative Cognitive Dysfunction [Phase 3]
Phase 3 trial update exploring donepezil to attenuate postoperative cognitive dysfunction.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy [Phase 2]
Phase 2 trial of RO7123520 in moderately to severely active rheumatoid arthritis that terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis [Phase 4]
An open-label Phase 4 study evaluating the failure rate of the Enbrel SureClick auto-injector in adults with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]
A comparative pharmacokinetic, pharmacodynamic, safety and efficacy study of three anti-CD20 monoclonal antibodies in patients with moderate…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
A completed clinical trial evaluating post-marketing use of CT-P13 (infliximab) for standard care in patients with rheumatoid diseases who a…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Clinical trial update on T cells and TNF blockade in inflammatory diseases; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 2]
Phase 2 study evaluating CKD-506 for efficacy and safety in adults with moderate-to-severe rheumatoid arthritis who did not respond to metho…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury [Phase 2]
Phase 2 trial of cobiprostone for prevention of NSAID-induced gastroduodenal injury completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment [NA]
Phase 3 DESIRABLE study evaluating denosumab (AMG 162) in participants with rheumatoid arthritis on DMARDs has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of SM03 in rheumatoid arthritis patients on methotrexate has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis [Phase 4]
Phase 4 trial update on methotrexate withdrawal in rheumatoid arthritis patients treated with tofacitinib modified-release formulation; resu…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection [Phase 3]
Phase 3 clinical trial update evaluating recombinant anti-TNF-alpha antibodies for rheumatoid arthritis; current status unknown.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis [Phase 4]
A Phase 4 trial comparing methotrexate combined with statins versus methotrexate alone in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating Sunpharma1505 versus Reference1505 in active rheumatoid arthritis was terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) [Phase 2]
Phase 2 pharmacokinetic/pharmacodynamic study comparing PF-05280586 to rituximab in rheumatoid arthritis patients with inadequate response t…
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging [Phase 1]
Phase 1 clinical trial evaluating Tc-99m tilmanocept localization in active rheumatoid arthritis subjects using SPECT and SPECT/CT imaging; …
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Tocilizumab REMission in Early RA [Phase 4]
A Phase 4 clinical trial update on tocilizumab in early rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Rosuvastatin in Rheumatoid Arthritis (RORA) [Phase 2, Phase 3]
Clinical trial update for rosuvastatin in rheumatoid arthritis across Phase 2 and Phase 3, indicating completion.